Skip to main content
null
prnano
  • Menu
  • Articles
    • Case study
    • Communication
    • Editorial
    • Editorial Policies
    • Expression of concern
    • Letters to the Editor
    • Perspective, Opinion, or Discussion
    • Research Article
    • Review
    • Technical Note
    • All
  • For Authors
  • Editorial Board
  • About
  • Issues
  • Blog
  • The Rising Talents List
  • Journal Policies
  • search
  • Facebook (opens in a new tab)
  • LinkedIn (opens in a new tab)
  • RSS feed (opens a modal with a link to feed)

RSS Feed

Enter the URL below into your favorite RSS reader.

http://localhost:31856/feed
ISSN 2639-9431
Technical Note
Vol. 4, Issue 2, 2021June 27, 2021 EDT

ViroStatics Testing Capabilities to Determine Efficacy of Drugs, Disinfectants or Devices against SARS-CoV-2

Barbara Poddesu, Ph.D., Giulia Cugia, Ph.D., Franco Lori, M.D., Ph.D., Davide De Forni, Ph.D.,
devicecytotoxicityefficacyvariantaerosolnatural substancecompounddrugsars-cov-2testing
Copyright Logoccby-nc-sa-4.0 • https://doi.org/10.33218/001c.25173
prnano
Poddesu, Barbara, Giulia Cugia, Franco Lori, and Davide De Forni. 2021. “ViroStatics Testing Capabilities to Determine Efficacy of Drugs, Disinfectants or Devices against SARS-CoV-2.” Precision Nanomedicine 4 (2): 801–4. https:/​/​doi.org/​10.33218/​001c.25173.

View more stats

This website uses cookies

We use cookies to enhance your experience and support COUNTER Metrics for transparent reporting of readership statistics. Cookie data is not sold to third parties or used for marketing purposes.

cookies
cookies
cookies
Powered by Scholastica, the modern academic journal management system